A promising approach to achieve safer, more effective, and more precise breast cancer treatment has earned a University of ...

Innoblative Designs announced today that it received FDA investigational device exemption (IDE) for its Sira RFA ...

The US Food and Drug Administration (FDA) has granted approval for Innoblative Designs' investigational device exemption (IDE ...

In a major step forward for cancer treatment, researchers have developed a new type of “smart” chemical that attacks ...

As the university advances plans for a new, state-of-the-art Cancer Research Building, leaders say the facility will pave the ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

UPDATE from LBL: The fire burned just over an acre and has been contained and extinguished. Land Between The Lakes–Land Between the Lakes Fire staff are currently working a wildfire that is moving ...

A fungating, or ulcerating, breast cancer is one in which the cancerous tissue breaks through the skin of the breast. This skin can start bleeding or weeping fluid, and the tumor can cause the skin to ...

Bruce Mann works as a surgeon at Northwestern BreastScreen in Melbourne. He was a board member of the Breast Cancer Network Australia, which has improved screening as a key strategic objective.

A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer. npj Breast Cancer , 2025; 11 (1) DOI: 10.1038/s41523-025-00742-x Cite This ...

Researchers have identified a previously unknown bacterial protein, the structure of which is being used in the design of protein ... approach in pre-clinical breast cancer models.

According to the World Health Organization (WHO), breast cancer was the most common cancer in women in ... The study also featured a novel design that reflected an unmet need in the indication, ...